Arabinofuranose disaccharide analogs as inhibitors of Mycobacterium tuberculosis

被引：18
|
作者：
Pathak, AK
Pathak, V
Kulshrestha, M
Kinnaird, D
Suling, WJ
Gurcha, SS
Besra, GS
Reynolds, RC
机构：
[1] So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA
[2] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
来源：
TETRAHEDRON | 2003年 / 59卷 / 51期
关键词：
Mycobacterium tuberculosis; glycosyltransferase; arabinofuranose; inhibitors;
D O I：
10.1016/j.tet.2003.10.054
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
Several octyl 5-O-(alpha-D-arabinofuranosyl)-alpha-D-arabinofuranoside disaccharide analogs substituted at the 5-position of the non-reducing end sugar were synthesized and tested in vitro against Mycobacterium tuberculosis (M.tb.), Mycobacterium avium complex (MAC) as well as in a cell free assay system for arabinosyltransferase acceptor/inhibitor activity. A few compounds showed interesting inhibitory activity in the cell free assay as well as against the whole microorganism in vitro. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码：10239 / 10248
页数：10
相关论文
共 50 条
  • [21] Advancement of Cell Wall Inhibitors in Mycobacterium tuberculosis
    Shirude, Pravin S.
    Chatterji, Monalisa
    Narayanan, Shridhar
    Iyer, Pravin S.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 209 - 220
  • [22] Allosteric inhibitors of Mycobacterium tuberculosis tryptophan synthase
    Michalska, Karolina
    Chang, Changsoo
    Maltseva, Natalia I.
    Jedrzejczak, Robert
    Robertson, Gregory T.
    Gusovsky, Fabian
    McCarren, Patrick
    Schreiber, Stuart L.
    Nag, Partha P.
    Joachimiak, Andrzej
    PROTEIN SCIENCE, 2020, 29 (03) : 779 - 788
  • [23] Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence
    Zheng H.
    Colvin C.J.
    Johnson B.K.
    Kirchhoff P.D.
    Wilson M.
    Jorgensen-Muga K.
    Larsen S.D.
    Abramovitch R.B.
    Nature Chemical Biology, 2017, 13 (2) : 218 - 225
  • [24] Psoralen Derivatives as Inhibitors of Mycobacterium tuberculosis Proteasome
    Rozman, Kaja
    Alexander, Evan M.
    Ogorevc, Eva
    Bozovicar, Kristof
    Sosic, Izidor
    Aldrich, Courtney C.
    Gobec, Stanislav
    MOLECULES, 2020, 25 (06):
  • [25] Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors
    Altaf, Mudassar
    Miller, Christopher H.
    Bellows, David S.
    O'Toole, Ronan
    TUBERCULOSIS, 2010, 90 (06) : 333 - 337
  • [26] Energy landscapes for disaccharide analogs
    French, Alfred D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [27] α-pyrones and their hydroxylated analogs as promising scaffolds against Mycobacterium tuberculosis
    Bhat, Zubair Shanib
    Rather, Muzafar Ahmad
    Syed, Khalid Yousuf
    Ahmad, Zahoor
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (17) : 2053 - 2067
  • [28] Predictive models for nucleoside bisubstrate analogs as inhibitors of siderophore biosynthesis in Mycobacterium tuberculosis: pharmacophore mapping and chemometric QSAR study
    Nilesh R. Tawari
    Mariam S. Degani
    Molecular Diversity, 2011, 15 : 435 - 444
  • [29] Predictive models for nucleoside bisubstrate analogs as inhibitors of siderophore biosynthesis in Mycobacterium tuberculosis: pharmacophore mapping and chemometric QSAR study
    Tawari, Nilesh R.
    Degani, Mariam S.
    MOLECULAR DIVERSITY, 2011, 15 (02) : 435 - 444
  • [30] Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2′-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors
    Shakya, Neeraj
    Srivastav, Naveen C.
    Bhavanam, Sudha
    Tse, Chris
    Desroches, Nancy
    Agrawal, Babita
    Kunimoto, Dennis Y.
    Kumar, Rakesh
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (13) : 4088 - 4097
12345